Period2 Oct 2018

Media coverage

1

Media coverage

  • TitlePhase II Study of Bevacizumab (Avastin®) in Myelofibrosis
    Media name/outletClinical Trials.gov
    Country/TerritoryUnited States
    Date2/10/18
    PersonsRonald Hoffman